B cells and tertiary lymphoid structures promote immunotherapy response

Beth A. Helmink(The University of Texas MD Anderson Cancer Center), Sangeetha M. Reddy(The University of Texas MD Anderson Cancer Center), Jianjun Gao(The University of Texas MD Anderson Cancer Center), Shaojun Zhang(The University of Texas MD Anderson Cancer Center), Rafet Başar(The University of Texas MD Anderson Cancer Center), Rohit Thakur(The University of Texas MD Anderson Cancer Center), Keren Yizhak(Massachusetts General Hospital), Moshe Sade-Feldman(Broad Institute), Jorge Blando(The University of Texas MD Anderson Cancer Center), Guangchun Han(The University of Texas MD Anderson Cancer Center), Vancheswaran Gopalakrishnan(The University of Texas MD Anderson Cancer Center), Yuanxin Xi(The University of Texas MD Anderson Cancer Center), Hao Zhao(The University of Texas MD Anderson Cancer Center), Rodabe Navroze Amaria(The University of Texas MD Anderson Cancer Center), Hussein Tawbi(The University of Texas MD Anderson Cancer Center), Alexandria P. Cogdill(The University of Texas MD Anderson Cancer Center), Wenbin Liu(The University of Texas MD Anderson Cancer Center), Valerie S. LeBleu(The University of Texas MD Anderson Cancer Center), Fernanda G. Kugeratski(The University of Texas MD Anderson Cancer Center), Sapna P. Patel(The University of Texas MD Anderson Cancer Center), Michael A. Davies(The University of Texas MD Anderson Cancer Center), Patrick Hwu(The University of Texas MD Anderson Cancer Center), Jeffrey E. Lee(The University of Texas MD Anderson Cancer Center), Jeffrey E. Gershenwald(The University of Texas MD Anderson Cancer Center), Anthony Lucci(The University of Texas MD Anderson Cancer Center), Reetakshi Arora(The University of Texas MD Anderson Cancer Center), Scott E. Woodman(The University of Texas MD Anderson Cancer Center), Emily Z. Keung(The University of Texas MD Anderson Cancer Center), Pierre-Olivier Gaudreau(The University of Texas MD Anderson Cancer Center), Alexandre Reuben(The University of Texas MD Anderson Cancer Center), Christine N. Spencer(Parker Institute for Cancer Immunotherapy), Elizabeth M. Burton(The University of Texas MD Anderson Cancer Center), Lauren E. Haydu(The University of Texas MD Anderson Cancer Center), Alexander J. Lazar(The University of Texas MD Anderson Cancer Center), Roberta Zapassodi(Memorial Sloan Kettering Cancer Center), Courtney W. Hudgens(The University of Texas MD Anderson Cancer Center), Deborah A. Ledesma(The University of Texas MD Anderson Cancer Center), SuFey Ong(Nanostring Technologies (United States)), Michael Bailey(Nanostring Technologies (United States)), Sarah Warren(Nanostring Technologies (United States)), Disha Rao(The Netherlands Cancer Institute), Oscar Krijgsman(The Netherlands Cancer Institute), Elisa A. Rozeman(The Netherlands Cancer Institute), Daniel S. Peeper(The Netherlands Cancer Institute), Christian U. Blank(The Netherlands Cancer Institute), Ton N. Schumacher(The Netherlands Cancer Institute), Lisa H. Butterfield(University of Pittsburgh), Monika A. Zelazowska(The University of Texas MD Anderson Cancer Center), Kevin M. McBride(The University of Texas MD Anderson Cancer Center), Raghu Kalluri(The University of Texas MD Anderson Cancer Center), James P. Allison(The University of Texas MD Anderson Cancer Center), Florent Petitprez(Délégation Paris 5), Wolf H. Fridman(Délégation Paris 5), Catherine Sautès‐Fridman(Délégation Paris 5), Nir Hacohen(Broad Institute), Katayoun Rezvani(The University of Texas MD Anderson Cancer Center), Padmanee Sharma(The University of Texas MD Anderson Cancer Center), Michael T. Tetzlaff(The University of Texas MD Anderson Cancer Center), Linghua Wang(The University of Texas MD Anderson Cancer Center), Jennifer A. Wargo(The University of Texas MD Anderson Cancer Center)
Nature
January 15, 2020
Cited by 2,627Open Access
Full Text

Abstract


Related Papers